Linkster Therapeutics is an early stage drug development company focusing on oncology and infectious diseases. Our two proprietary technology platforms enable a targeted approach to create functional large molecule drugs acting on high hanging fruit targets such as integral membrane proteins, holding the promise to create the next blockbuster drugs. The Linkster approach can create biologic drug candidates more reliable, less expensive and faster than traditional drug development pipelines, thus making Linkster an attractive partner for large pharma companies.
- Iwan Zimmermann
- Pascal Egloff
Iwan Zimmermann firstname.lastname@example.org